Stocksigma LogoStocksigma Logo

Acutaas Chemicals Delivers Robust Q2 FY27 Results and Upgrades Full-Year Guidance

Acutaas Chemicals reported strong Q2 FY27 results, with revenue rising 42.7% YoY to ₹4,369 Mn, EBITDA surging 84.6% YoY to ₹1,760 Mn (margin expanded to

Acutaas Chemicals Delivers Robust Q2 FY27 Results and Upgrades Full-Year Guidance

Acutaas Chemicals Ltd · Investor Presentation · 27 Oct 2026, 6:35 pm

Acutaas Chemicals Delivers Robust Q2 FY27 Results and Upgrades Full-Year Guidance Acutaas Chemicals reported strong Q2 FY27 results, with revenue rising 42.7% YoY to ₹4,369 Mn, EBITDA surging 84.6% YoY to ₹1,760 Mn (margin expanded to 40.3%), and PAT climbing 71.4% YoY to ₹1,231 Mn. Growth was powered by Pharma Intermediates (up 53.1% YoY to ₹4,020 Mn), offsetting softness in Specialty Chemicals. Ahead of schedule, the company inaugurated its South Korea facility for semiconductor chemicals. Backed by solid visibility, management raised FY27 revenue growth guidance to ~30% and EBITDA margin guidance to 38–40%.

Original exchange filing (PDF)

More announcements from Acutaas Chemicals Ltd

All Acutaas Chemicals Ltd announcements